Resources from the same session
Present standard of care for recurrent glioblastoma
Presenter: Emilie Le Rhun
Session: ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities
Resources:
Slides
CD95L/Fas ligand selective inhibition: Rationale and clinical results
Presenter: Wolfgang Wick
Session: ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities
Resources:
Slides
Webcast